Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Details)

v2.4.0.6
Financial Instruments (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2012
Sep. 30, 2011
Jul. 12, 2012
Financial Instruments [Abstract]            
Foreign currency transaction gains and (losses)       $ 0 $ 29  
Number of open foreign exchange contracts 0     0    
Class of Warrant or Right [Line Items]            
Warrants outstanding (in shares) 285,454     285,454    
Non cash gains on warrants 2 3 14 3 14  
Note receivable - CollabRx 0     0    
Debt extinguishment as a consideration of acquisition       300    
Promissory note liability assumed as a purchase price of acquisition $ 500     $ 500   $ 500
Liability Warrants Having Exercise Price 30 [Member]
           
Class of Warrant or Right [Line Items]            
Warrants outstanding (in shares) 8,348 41,741   8,348 41,741  
Exercise price of warrants outstanding (in dollars per share) $ 30.00 $ 30.00   $ 30.00 $ 30.00